Please login to the form below

Not currently logged in
Email:
Password:

Sir Philip Hampton set to be new GSK chair

RBS chairman to replace Sir Christopher Gent

philip hampton gskGlaxoSmithKline (GSK) is set to name the Royal Bank of Scotland's (RBS) Sir Philip Hampton as the company's new chairman, according to local reports.

Several UK media outlets have published stories suggesting GSK will this week officially announce Sir Philip (pictured) as chairman-designate, replacing Sir Christopher Gent when he steps down in 2015.

The news come at a time of pressure for GSK after the company was recently hit with a $487m fine for illegal marketing practices in China.

Sir Philip has served as chairman of the board at RBS since 2009, overseeing the company during a time of global economic collapse.

He has experience in a wide variety of industries, with previous roles including chairman of Sainsbury's and as group finance directory at Lloyds TSB, BT Group, BG Group, British Gas and British Steel.

He is also a former chairman of UK Financial Investments Limited, which manages the UK Government's shareholdings in banks.


25th September 2014

From: Research, Sales

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
TRIDUCIVE

Hello we’re Triducive. We’re a healthcare strategy and value consultancy that provides expert and insight-driven solutions that strengthen and realise...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics